Back to Search
JAROSLAW JAC, MD
MD
Hematology & Oncology Physician
NPI: 1326029802IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
35312(NH)238060(MA)
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD13980(ME)35312(NH)J9106(TX)238060(MA)
Education
OTHER
Class of 1990
Research & Publications (7)
Vaccination of renal cell cancer patients with modified vaccinia Ankara delivering the tumor antigen 5T4 (TroVax) alone or administered in combination with interferon-alpha (IFN-alpha): a phase 2 trial.
PMID 19561532·J Immunother·2009
3-trial
A phase 2 study with a daily regimen of the oral mTOR inhibitor RAD001 (everolimus) in patients with metastatic clear cell renal cell cancer.
PMID 19306412·Cancer·2009
3-trial
Vaccination of renal cell cancer patients with modified vaccinia ankara delivering tumor antigen 5T4 (TroVax) administered with interleukin 2: a phase II trial.
PMID 19010868·Clin Cancer Res·2008
3-trial
Pilot study of rapamycin in patients with hormone-refractory prostate cancer.
PMID 18824432·Clin Genitourin Cancer·2008
8-other
Motexafin gadolinium for the treatment of metastatic renal cell carcinoma: phase II study results.
PMID 18824428·Clin Genitourin Cancer·2008
3-trial
Interferon-alpha in combination with either imatinib (Gleevec) or gefitinib (Iressa) in metastatic renal cell carcinoma: a phase II trial.
PMID 18418219·Anticancer Drugs·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 3073 WHITE MOUNTAIN HWY
NORTH CONWAY, NH 03860 - Phone
- (603) 356-4904
Quick Facts
- NPI
- 1326029802
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 6
- Locations
- 2
- Years in Practice
- 36
- Publications
- 7
Are you this provider?
Claim Your Profile